Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Palladyne AI (PDYNW) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Palladyne AI (PDYNW) over the last 6 years, with Q3 2025 value amounting to $27.4 million.

  • Palladyne AI's Cash & Equivalents rose 2828.68% to $27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 2828.68%. This contributed to the annual value of $31.2 million for FY2024, which is 3478.54% up from last year.
  • As of Q3 2025, Palladyne AI's Cash & Equivalents stood at $27.4 million, which was up 2828.68% from $20.1 million recorded in Q2 2025.
  • In the past 5 years, Palladyne AI's Cash & Equivalents ranged from a high of $239.1 million in Q3 2021 and a low of $14538.0 during Q2 2021
  • In the last 5 years, Palladyne AI's Cash & Equivalents had a median value of $31.8 million in 2024 and averaged $70.3 million.
  • In the last 5 years, Palladyne AI's Cash & Equivalents skyrocketed by 89028382.17% in 2022 and then tumbled by 7083.45% in 2023.
  • Over the past 5 years, Palladyne AI's Cash & Equivalents (Quarter) stood at $217.1 million in 2021, then crashed by 63.46% to $79.3 million in 2022, then crashed by 70.83% to $23.1 million in 2023, then soared by 34.79% to $31.2 million in 2024, then decreased by 12.27% to $27.4 million in 2025.
  • Its Cash & Equivalents stands at $27.4 million for Q3 2025, versus $20.1 million for Q2 2025 and $10.1 million for Q1 2025.